Moreover, blocking the MEK1/2 pathway reduces bacterial load and mitigates bone destruction in mice with osteomyelitis, suggesting that targeting the MEK1/2 pathway may be a potential therapeutic approach to restore compromised immunity in chronic S. aureus osteomyelitis. The gene discussed is MAP2K1; the disease is osteomyelitis.